A Brief review of Circulating MicroRNAs and Essential Hypertension | ||
| Records of Pharmaceutical and Biomedical Sciences | ||
| Article 4, Volume 2, Issue 2, September 2018, Pages 32-45 PDF (553.68 K) | ||
| Document Type: Mini-reviews | ||
| DOI: 10.21608/rpbs.2018.5986.1016 | ||
| Authors | ||
| Heba Kamel Badawy* 1; Noha Kamel Mesbah2; Dina Mohamed Abo-El-Matty3 | ||
| 1Biochemistry department, faculty of pharmacy, Sinai university, El-Arish, North Sinai | ||
| 2Biochemistry department, faculty of pharmacy, Suez canal university, Ismailia, Egypt | ||
| 3Faculty of Pharmacy - Suez Canal University, Ismailia, Egypt | ||
| Abstract | ||
| Essential hypertension is a chronic medical condition affecting thousands of people worldwide. It is polygenic and multi-factorial disease resulting from the interaction between genetic and environmental factors. Essential hypertension is implicated in cerebrovascular, cardiovascular and renal diseases. MicroRNAs are considered endogenous, non-coding regulators of gene expression by targeting specific mRNAs for degradation and/ or translational repression. MicroRNAs participate in a variety of developmental processes as metabolism, cell proliferation, and apoptosis. Many studies have reported the possibility of using miRNAs as new biological markers for polygenic diseases as cancer, stem cell aging, coronary heart disease, and essential hypertension. The stability of these miRNAs as miRNA let-7e, miRNA 296-5p, miRNA 605, and miRNA 623 in biological fluids makes them amenable to detection and quantification. This review summarizes the mechanisms by which miRNAs can control normal cellular processes and gene expression and the association of some circulating miRNAs with the incidence of different diseases, particularly essential hypertension. | ||
| Keywords | ||
| Essential hypertension; microRNA Let-7e; miRNA 296-5p; miRNA 605; miRNA 623 | ||
|
Statistics Article View: 400 PDF Download: 414 |
||
